These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32068236)

  • 1. SKA3 promotes lung adenocarcinoma metastasis through the EGFR-PI3K-Akt axis.
    Hu DD; Chen HL; Lou LM; Zhang H; Yang GL
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32068236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
    Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
    Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y
    Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mRNA expression of programmed cell death ligand 1 and components of the phosphatidylinositol 3-kinase/AKT/phosphatase and tensin homolog pathway in epidermal growth factor receptor mutation-positive lung adenocarcinoma.
    Han K; Zhang Y
    J Cancer Res Ther; 2019; 15(4):914-920. PubMed ID: 31436252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APE1 stimulates EGFR-TKI resistance by activating Akt signaling through a redox-dependent mechanism in lung adenocarcinoma.
    Lu GS; Li M; Xu CX; Wang D
    Cell Death Dis; 2018 Oct; 9(11):1111. PubMed ID: 30382076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mex3a interacts with LAMA2 to promote lung adenocarcinoma metastasis via PI3K/AKT pathway.
    Liang J; Li H; Han J; Jiang J; Wang J; Li Y; Feng Z; Zhao R; Sun Z; Lv B; Tian H
    Cell Death Dis; 2020 Aug; 11(8):614. PubMed ID: 32792503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis.
    Jiang L; Wang R; Fang L; Ge X; Chen L; Zhou M; Zhou Y; Xiong W; Hu Y; Tang X; Li G; Li Z
    Theranostics; 2019; 9(9):2460-2474. PubMed ID: 31131047
    [No Abstract]   [Full Text] [Related]  

  • 8. Targeting SKA3 suppresses the proliferation and chemoresistance of laryngeal squamous cell carcinoma via impairing PLK1-AKT axis-mediated glycolysis.
    Gao W; Zhang Y; Luo H; Niu M; Zheng X; Hu W; Cui J; Xue X; Bo Y; Dai F; Lu Y; Yang D; Guo Y; Guo H; Li H; Zhang Y; Yang T; Li L; Zhang L; Hou R; Wen S; An C; Ma T; Jin L; Xu W; Wu Y
    Cell Death Dis; 2020 Oct; 11(10):919. PubMed ID: 33106477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SLC39A5 promotes lung adenocarcinoma cell proliferation by activating PI3K/AKT signaling.
    Liu Z; Hu Z; Cai X; Liu S
    Pathol Res Pract; 2021 Aug; 224():153541. PubMed ID: 34252710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of spindle and kinetochore associated complex subunit 3 suppresses the proliferation and invasion and induced the apoptosis of cutaneous melanoma by affecting the PI3K/Akt pathway.
    Liang Y; Zheng Y; Mou K; Han D; Wang L; Ge R; Meng A
    J Biochem Mol Toxicol; 2021 Nov; 35(11):e22895. PubMed ID: 34423490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA (let-7b-5p)-targeted DARS2 regulates lung adenocarcinoma growth by PI3K/AKT signaling pathway.
    Xu Y; Chen X
    Oncol Res; 2024; 32(3):517-528. PubMed ID: 38361754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Grb2-associated binder 2 silencing impairs growth and migration of H1975 cells via modulation of PI3K-Akt signaling.
    Wang WJ; Mou K; Wu XF; Zhang JZ; Ren G; Qi JD; Xu YF; Yao X
    Int J Clin Exp Pathol; 2015; 8(9):10575-84. PubMed ID: 26617767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GABRA3 promotes lymphatic metastasis in lung adenocarcinoma by mediating upregulation of matrix metalloproteinases.
    Liu L; Yang C; Shen J; Huang L; Lin W; Tang H; Liang W; Shao W; Zhang H; He J
    Oncotarget; 2016 May; 7(22):32341-50. PubMed ID: 27081042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular RNA CDR1-AS contributes to pemetrexed and cisplatin chemoresistance through EGFR/PI3K signaling pathway in lung adenocarcinoma.
    Mao Y; Xu R
    Biomed Pharmacother; 2020 Mar; 123():109771. PubMed ID: 31881486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signaling through the Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Axis Is Responsible for Aerobic Glycolysis mediated by Glucose Transporter in Epidermal Growth Factor Receptor (EGFR)-mutated Lung Adenocarcinoma.
    Makinoshima H; Takita M; Saruwatari K; Umemura S; Obata Y; Ishii G; Matsumoto S; Sugiyama E; Ochiai A; Abe R; Goto K; Esumi H; Tsuchihara K
    J Biol Chem; 2015 Jul; 290(28):17495-504. PubMed ID: 26023239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of SKA3 enhances cell proliferation and correlates with poor prognosis in hepatocellular carcinoma.
    Tang J; Liu J; Li J; Liang Z; Zeng K; Li H; Zhao Z; Zhou L; Jiang N
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33760206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IGF2BP3 aggravates lung adenocarcinoma progression by modulation of PI3K/AKT signaling pathway.
    Chen X; Zhu X; Shen X; Liu Y; Fu W; Wang B
    Immunopharmacol Immunotoxicol; 2023 Jun; 45(3):370-377. PubMed ID: 36972188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-133b suppresses the proliferation, migration and invasion of lung adenocarcinoma cells by targeting SKA3.
    Zhang M; Lan X; Chen Y
    Cancer Biol Ther; 2021 Dec; 22(10-12):571-578. PubMed ID: 34711122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agmatinase promotes the lung adenocarcinoma tumorigenesis by activating the NO-MAPKs-PI3K/Akt pathway.
    Zhu HE; Yin JY; Chen DX; He S; Chen H
    Cell Death Dis; 2019 Nov; 10(11):854. PubMed ID: 31699997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TFAP2A Upregulates SKA3 to Promote Glycolysis and Reduce the Sensitivity of Lung Adenocarcinoma Cells to Cisplatin.
    Liu G; Liu X; Zeng W; Zhou W
    Pharmacology; 2024; 109(4):202-215. PubMed ID: 38643755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.